Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostate Adenocarcinoma 1 Breast Neoplasms 1

Interventions

Radiosurgery 4 Magnetic Resonance Spectroscopy 4 luprolide acetate gel depot 3 enzalutamide 3 Radiotherapy 3 Radiation 3 Leuprolide 3 Goserelin 3 relugolix 2 gallium 68 PSMA-11 2 bicalutamide 2 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 2 Triptorelin Pamoate 2 Specimen Handling 2 Biopsy 2 radium Ra 223 dichloride 1 niraparib 1 histrelin 1 fluciclovine F-18 1 flibanserin 1 entinostat 1 darolutamide 1 atezolizumab 1 apalutamide 1 abiraterone 1 X-Rays 1 Watchful Waiting 1 Salicylic Acid 1 Receptors, Bombesin 1 Radium-223 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Prostate Adenocarcinoma × flibanserin × Clear all

NCT04743934 2025-05-04

RAD 2003

University of Alabama at Birmingham

Phase 2 Active not recruiting

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡